Results 81 to 90 of about 527 (122)

Újszerű terápiás lehetőségek hipertrófiás obstruktív kardiomiopátiában: Miozin inhibitorok

A hipertrófiás obstruktív kardiomiopátia (HOCM) napjaink egyik leggyakoribb genetikai eredetű szívbetegsége, mely jelentős életminőség-romlást okozhat, súlyos esetben pedig a hirtelen szívhalál kockázatának növekedésével jár.
Singlár, Fanni
core  

Hypertrophic Cardiomyopathy in the Era of Precision Medicine: Redefining Diagnosis, Therapeutics and Risk. [PDF]

Card Fail Rev
Saldarriaga C.
europepmc   +1 more source

Myosin Modulators Mavacamten and Aficamten Inhibit Cardiac Contractility Through Different Mechanisms

Journal of Molecular and Cellular Cardiology Plus
Saffie Mohran, Kristina Kooiker, Galina Flint, Max Mahoney-Schaefer, Weikang Ma, Timothy McMillen, Thomas Irving, Michael Regnier, Farid Moussavi-Harami   +8 more
doaj   +1 more source

Severe dynamic left-ventricular outflow-tract obstruction unmasked by transcatheter aortic valve implantation: a case report. [PDF]

Eur Heart J Case Rep
Gao Z, Yuan M, Li Y, Lu J, Li R.
europepmc   +1 more source

Incidence of Ventricular Arrhythmias and Sudden Cardiac Death with Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. [PDF]

J Pers Med
Katic J, Bulum T, Borovac JA.
europepmc   +1 more source

A comprehensive review of small molecule drugs approved by the FDA in 2025: advance and prospect. [PDF]

J Enzyme Inhib Med Chem
Bai YR, Li R, Zhang XH, Seng DJ, Xu Y, Zhang SY, Yuan S.   +6 more
europepmc   +1 more source

Hypertrophic cardiomyopathy: state of the art on diagnosis and current therapeutic approach. [PDF]

Cardiovasc Ultrasound
La Franca E, Parisi F, Lucchino A, Sade LE, Wong T, Loddo I, Alioto L, Gentile G, Pilato M, Cipriani M, Faletra FF.   +10 more
europepmc   +1 more source

Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: Clinical Advances and Therapeutic Prospects. [PDF]

Drug Des Devel Ther
Hou L, Lin B, Ji X, Huang A.
europepmc   +1 more source

Aficamten in the treatment of obstructive hypertrophic cardiomyopathy. [PDF]

Future Cardiol
Saleh D, Eskandari M, Choudhury L.
europepmc   +1 more source

Pharmacologic therapies for hypertrophic cardiomyopathy: The past, the present, and the future. [PDF]

JRSM Cardiovasc Dis
Halațiu VB, Cozac DA, Scridon A.
europepmc   +1 more source